MyFinsight
Home
Blog
About
Income Statement
|
Cash Flow
|
Balance Sheet
|
Ratios
Income Overview
Revenue
$755K
Net Income
-$8,098K
Net Profit Margin
-1072.58%
EPS
-$0.14
Unit: Thousand (K) dollars
Subscribe for Financial Insights
Page 1
Quarterly
123
Page 1
Income Statement
2026-06-30
2025-12-31
2025-09-30
2025-06-30
License and collaborations revenue
755
3,865
3,079
2,882
Research and development
11,207
10,428
6,409
6,022
General and administrative
6,028
4,890
4,981
5,766
Acquired in-process research and development
-
0
-
-
Total operating expenses
17,235
15,318
11,390
11,788
Loss from operations
-16,480
-11,453
-8,311
-8,906
Fair value change in warrant and other derivative liabilities
-
-5,712
-9,525
917
Fair value change in instruments measured at fair value
7,174
-
-
-
Financing costs
531
0
0
-35
Interest expense
-
61
68
-
Other income, net
1,739
703
450
534
Loss before income taxes
-8,098
-16,523
-17,454
-7,420
Benefit (provision) for income taxes
0
0
0
0
Net loss
-8,098
-16,523
-17,454
-7,420
Other comprehensive loss, net of tax
0
0
0
0
Comprehensive loss
-8,098
-16,523
-17,454
-7,420
Basic EPS
-0.08
-0.266
-0.25
-0.12
Diluted EPS
-0.14
-0.266
-0.25
-0.12
Basic Average Shares
95,483,280
62,221,901*
70,636,887
63,376,392
Diluted Average Shares
111,384,011
62,221,901*
70,636,887
63,376,392
Page 1
Unit: Thousand (K) dollars (except for numbers of shares and EPS). Numbers labeled with * are estimated quarterly values.
Page 1
Buy us a coffee
Time Plot
Show the time plot by selecting a row from the table.
Income Statement
Comprehensive loss
-$8,098K
(-9.14%↓ Y/Y)
Net loss
-$8,098K
(-9.14%↓ Y/Y)
Loss before income
taxes
-$8,098K
(-9.14%↓ Y/Y)
Fair value change in
instruments measured at fair...
$7,174K
Other income, net
$1,739K
(225.66%↑ Y/Y)
Loss from operations
-$16,480K
(-85.04%↓ Y/Y)
License and
collaborations revenue
$755K
(-73.80%↓ Y/Y)
Financing costs
$531K
(1617.14%↑ Y/Y)
Total operating
expenses
$17,235K
(46.21%↑ Y/Y)
Research and development
$11,207K
(86.10%↑ Y/Y)
General and
administrative
$6,028K
(4.54%↑ Y/Y)
Buy us a coffee
Opus Genetics, Inc. (IRD)
Opus Genetics, Inc. (IRD)